HEALTH SOLUTIONS
Life sciences
Experts in healthcare access
The access challenges facing healthcare products are becoming more and more complex. With direct experience serving stakeholders across the U.S. healthcare system, we can help you understand the market, identify actionable insights, develop market-ready strategies, and execute to the top of your potential.
Our solutions are tailored to your needs, whether you’re focused on small molecule pharma, gene and cell therapies, rare disease, biosimilars, or medical devices.
Hear from
Milliman Life Sciences leaders
Watch our experts in conversation on key topics affecting the industry.
Read our latest thought leadership
Learn more about our comprehensive suite of services
Market access strategy
Develop strategies and tactics that drive product access.
With expertise in payer, pharmacy benefit managers (PBM), and integrated delivery networks (IDNs), we can help you identify access opportunities specific to your products. We speak your customers’ language, informed by our industry knowledge and supported by unbeatable pharmacy and medical data.
Health economics and outcomes research
Create the studies and evidence that support your value proposition.
Our cross-functional team of experts can help you advance your health economic or medical- affairs strategy, regardless of where your product is in its life cycle.
Policy research and analysis
Navigate the ever-changing policy landscape.
From proposed rule to policy, our team of experts can help you understand the spirit, implementation, and potential impact of health policy. From your perspective or your customers’, we analyze relevant scenarios, driving toward actionable strategies and tactical response.
Payer and access agency support
Creative experts who know access.
Our full-service agency uses a data-driven approach to identify opportunities and develop the strategies and tactics to unlock performance. Our clinicians, strategists, and creatives have extensive experience in launch-readiness planning and optimization for in-line products.
Specialty pharmacy and hub support
Thoughtful design for the patient experience.
Getting your therapies to patients requires successfully engaging a complex and highly regulated landscape. Whether you’re looking to establish a new distribution strategy, access mail-order distributors, work with a specialty pharmacy network, or pursue other pharma supply chain strategies, we can help.
Business development
Better assumptions to size the opportunity.
Our team of experts can help teams to size an opportunity and estimate how the U.S. healthcare system may impact an asset’s potential future revenue.
Milliman Consolidated Health Cost Guidelines™ databases
Claim line detail for medical and prescription drug claims and enrollment.
Heading | Content | Lines of business | Estimated lives represented | |
---|---|---|---|---|
Milliman Proprietary Data | CHSD+ | The Consolidated Health Cost Guidelines Databases (CHSD) includes claim line detail for medical and prescription drug claims and enrollment | Commercial Medicare Advantage Managed Medicaid |
Almost 90 million |
Milliman Proprietary Data | Medicare PDCD | The Medicare Prescription Drug Consolidated Database includes drug claims and enrollment | Medicare Part D | Over 6 million |
Industry Data | CMS 100% Research Identifiable Files | Claim line detail for medical and prescription drug claims and enrollment | Fee-for-service (FFS) Medicare Medicare Advantage Medicaid |
All beneficiaries |
Industry Data | CMS 5% Sample / 100% Data Sets | Claim line detail for medical claims and enrollment | Fee-for-Service (FFS) Medicare | All beneficiaries |
Industry Data | MarketScan | Claim line detail for medical and prescription drug claims and enrollment | Commercial | 35 million |
Milliman Proprietary Data | State Discharge | Inpatient discharges, no membership | All | 100% of Admissions in Available States |